{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T18:42:37Z","timestamp":1779043357709,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.euroneuro.2015.04.010","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T23:12:31Z","timestamp":1429312351000},"page":"1147-1157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Anti-depressant therapy and cancer risk: A nested case-control study"],"prefix":"10.1016","volume":"25","author":[{"given":"Ben","family":"Boursi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8033-2432","authenticated-orcid":false,"given":"Ido","family":"Lurie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronac","family":"Mamtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2015.04.010_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2006.04.053","article-title":"Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cells","volume":"541","author":"Arimochi","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1741-7015-8-90","article-title":"A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency","volume":"8","author":"Ashbury","year":"2010","journal-title":"BMC Med."},{"issue":"2","key":"10.1016\/j.euroneuro.2015.04.010_bib3","first-page":"177","article-title":"Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants, prolactin and breast cancer","volume":"5","author":"Ashbury","year":"2012","journal-title":"Front. Oncol."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib4","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim. Care"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib5","first-page":"171","article-title":"Feasibility study and methodology to create a quality-evaluated database of primary care data","volume":"12","author":"Bourke","year":"2004","journal-title":"Inform Prim. Care"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib6","first-page":"3796","article-title":"Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses","volume":"52","author":"Brandes","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0006-291X(85)90271-2","article-title":"Evidence that the antiestrogen binding site is a histamine or histamine-like receptor","volume":"126","author":"Brandes","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ijc.25322","article-title":"Colorectal cancer risk in relation to antidepressant medication use","volume":"128","author":"Chubak","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/aje\/kwi301","article-title":"Use of selective serotonin reuptake inhibitors and the risk of breast cancer","volume":"162","author":"Coogan","year":"2005","journal-title":"Am. J. Epidemiol."},{"issue":"109","key":"10.1016\/j.euroneuro.2015.04.010_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10549-007-9664-y","article-title":"SSRI use and breast cancer risk by hormone receptor status","volume":"2008","author":"Coogan","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/pds.1808","article-title":"Antidepressant use and colorectal cancer risk","volume":"18","author":"Coogan","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/oxfordjournals.aje.a010138","article-title":"Antidepressant medication use and breast cancer risk","volume":"151","author":"Cotterchio","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/sj.bjc.6605911","article-title":"Antidepressant use and colorectal cancer risk: a Danish population-based case-control study","volume":"104","author":"Cronin-Fenton","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10549-012-2307-y","article-title":"Use of antidepressants and the risk of breast cancer: a meta-analysis","volume":"136","author":"Eom","year":"2012","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ijc.24063","article-title":"Is norepinephrine an etiological factor in some types of cancer?","volume":"124","author":"Fitzgerald","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/01.ede.0000147103.92638.c0","article-title":"Breast cancer risk among users of antidepressant medications","volume":"16","author":"Gonz\u00e1lez-P\u00e9rez","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2004.11.003","article-title":"Breast cancer risk in a large cohort of female antidepressant medication users","volume":"221","author":"Haque","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.24537","article-title":"Incidence of cancer and antidepressant medication: record linkage study","volume":"126","author":"Haukka","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib19","first-page":"36","article-title":"The general practice research database: quality of morbidity data","volume":"87","author":"Hollowell","year":"1997","journal-title":"Popul. Trends"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib20","unstructured":"HSCIC: Statistics on Obesity, Physical Activity and Diet\u2014England, 2012. \u3008http:\/\/www.hscic.gov.uk\/catalogue\/PUB05131\/obes-phys-acti-diet-eng-2012-rep.pdf\u3009 Accessed January 12, 2015."},{"issue":"11","key":"10.1016\/j.euroneuro.2015.04.010_bib21","doi-asserted-by":"crossref","first-page":"e50043","DOI":"10.1371\/journal.pone.0050043","article-title":"Anti-proliferative effects of fluoxetine on colon cancer cells and in a colonic carcinogen mouse model","volume":"7","author":"Kannen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.toxlet.2011.04.024","article-title":"Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats","volume":"204","author":"Kannen","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/oxfordjournals.aje.a010091","article-title":"Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines","volume":"150","author":"Kelly","year":"1999","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/MEG.0b013e328355e289","article-title":"Meta-analysis: selective serotonin reuptake inhibitors and colon cancer","volume":"24","author":"Lee","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pds.1115","article-title":"The relationship between time since registration and measured incidence rates in the general practice research database","volume":"14","author":"Lewis","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol. Drug Safe"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib27","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2307\/2530744","article-title":"Biased selection of controls for case-control analysis of cohort studies","volume":"40","author":"Lubin","year":"1984","journal-title":"Biometrics"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pds.1688","article-title":"The importance of defining periods of complete mortality reporting for research using automated data from primary care","volume":"18","author":"Maguire","year":"2009","journal-title":"Pharmacoepidemiol. Drug Safe"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.EDE.0000050695.99660.D1","article-title":"Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast","volume":"14","author":"Moorman","year":"2003","journal-title":"Epidemiology"},{"issue":"4","key":"10.1016\/j.euroneuro.2015.04.010_bib500","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/01.AOG.0000157113.98061.eb","article-title":"Antidepressant medication use [corrected] and risk of ovarian cancer","volume":"Apr;105","author":"Moorman","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib31","unstructured":"National Center for Health Statistics. Health, United States, 2010: With Special Feature on Death and Dying. Table 95. Hyattsville, MD. 2011."},{"issue":"Suppl 2","key":"10.1016\/j.euroneuro.2015.04.010_bib32","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1038\/bjc.2011.489","article-title":"The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010","volume":"105","author":"Parkin","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/sj.bjc.6600013","article-title":"The effects of tricyclic antidepressants on breast cancer risk","volume":"86","author":"Sharpe","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib34","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2013.2813","article-title":"Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial","volume":"309","author":"Smith","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib35","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4161\/cbt.7.10.6664","article-title":"Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells","volume":"7","author":"Stepulak","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/pds.1233","article-title":"Risk of breast cancer in association with exposure to two different groups of tricyclic antidepressants","volume":"15","author":"Tamim","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.pcan.4501003","article-title":"Antidepressants and risk of prostate cancer: a nested case-control study","volume":"11","author":"Tamim","year":"2008","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s10552-007-9045-1","article-title":"Use of antidepressants and risk of lung cancer","volume":"18","author":"Toh","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/bjc.1982.191","article-title":"Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas","volume":"46","author":"Tutton","year":"1982","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib40","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1158\/0008-5472.CAN-13-3540","article-title":"Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene expression profiling","volume":"74","author":"van Noort","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-1218(91)90085-Z","article-title":"Genotoxicity evaluation of five tricyclic antidepressants in the wing somatic mutation and recombination test in Drosophila melanogaster","volume":"260","author":"van Schaik","year":"1991","journal-title":"Mutat. Res."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bjc.6605996","article-title":"Tricyclic antidepressants and the incidence of certain cancers: a study using the GPRD","volume":"104","author":"Walker","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.euroneuro.2015.04.010_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1470-2045(06)70622-2","article-title":"Use of antidepressants and risk of colorectal cancer: a nested case-control study","volume":"7","author":"Xu","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.euroneuro.2015.04.010_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.mayocp.2013.04.021","article-title":"Age and sex patterns of drug prescribing in a defined American population","volume":"88","author":"Zhong","year":"2013","journal-title":"Mayo Clin. Proc."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15001133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X15001133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T07:55:47Z","timestamp":1537689347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X15001133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0924977X15001133"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.04.010","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-depressant therapy and cancer risk: A nested case-control study","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2015.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}